Press Releases

First and only immunostimulatory antibody approved in the European Union for multiple myeloma Accelerated assessment and approval based on long-term data from ELOQUENT-2, which evaluated Empliciti in combination with Revlimid®(lenalidomide) and dexamethasone (Rd). ELOQUENT-2 demonstrated...

Opdivo + Yervoy Regimen now approved for unresectable or metastatic melanoma patients, regardless of BRAF mutational status Approval of the Regimen marks a novel combination treatment for advanced melanoma patients, demonstrating the potential of targeting distinct and...

Johnson & Johnson Innovation LLC announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices, modular lab suites and access to scientific, industry and capital funding experts as they...

Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for laboratory technology, analysis and biotechnology, held May 10-13 in Munich, Germany. Innovations...

Baxter International Inc will present at the 2016 UBS Global Healthcare Conference on Monday, May 23 in New York, NY. Jay Saccaro, corporate vice president and chief financial officer, is scheduled to present at 9:00 a.m. (CDT). ...

AbbVie a global biopharmaceutical company announced the U.S. Food and Drug Administration (FDA) updated the IMBRUVICA® (ibrutinib) Prescribing Information (PI) to include new data from two Phase 3 trials supporting its expanded use in patients with chronic lymphocytic leukemia...

Merck, a leading science and technology company, today announced the global launch of the first commercially-available equine-specific multiplex assay for protein biomarkers. The assay is intended for research use only, not for use in diagnostic procedures. ...